Rapidly Spreading Multi-Drug Resistant Yeast: Candida auris

Invasive Infections with Multidrug-Resistant Yeast Candida auris, Colombia

Candida auris is an emerging multidrug-resistant fungus that causes a wide range of symptoms. We report finding 17 cases of C. auris infection that were originally misclassified but correctly identified 27.5 days later on average. Patients with a delayed diagnosis of C. auris had a 30-day mortality rate of 35.2%.

Secrets of the antibiotic resistant Candida auris

Most fossils from the Pre-Cambrian that were claimed to perhaps be fungal have proved to be artefacts or otherwise dubious (Hawksworth 2015, Taylor et al. 2015). Some more convincing remains of mycelium-like structures have, however, now been reported from a 2.4 billion-year-old basalt from the Palaeoproterozoic of the Pre-Cambrian in South Africa (Bengston et al. 2017). The basalts were submar...

Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally

Candidiasis, which includes both superficial infections and invasive disease, is the most common cause of fungal infection worldwide. Candida bloodstream infections (BSI) cause significant mortality and elicit a major threat to intensive care unit (ICU) patients [1]. The annual global burden of Candida spp. BSIs is about 400,000 cases, with most cases reported from the developed world. Although...

Candidemia caused by amphotericin B and fluconazole resistant Candida auris.

Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel

Candida auris and C. haemulonii are closely related, multidrug-resistant emerging fungal pathogens that are not readily distinguishable with phenotypic assays. We studied C. auris and C. haemulonii clinical isolates from 2 hospitals in central Israel. C. auris was isolated in 5 patients with nosocomial bloodstream infection, and C. haemulonii was found as a colonizer of leg wounds at a peripher...